# Endra Life Sciences (NDRA) — Earnings

NDRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ndra/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$2.10 |
| EPS estimate | −$1.95 |
| EPS surprise | −7.69% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1681682/000121390025110887/ea0265291-10q_endra.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 14, 2025 | −$1.95 | −$2.10 | -7.69% | — | — |
| Q2 2025 | Aug 14, 2025 | −$2.27 | −$1.71 | 24.67% | — | — |
| Q1 2025 | May 15, 2025 | −$3.91 | −$1.86 | 52.43% | — | — |
| Q4 2024 | Mar 31, 2025 | −$4.10 | −$47.06 | -1047.80% | — | — |
| Q3 2024 | Nov 15, 2024 | −$62.30 | −$9.54 | 84.69% | — | — |
| Q2 2024 | Aug 14, 2024 | −$122.50 | −$140.00 | -14.29% | — | — |
| Q1 2024 | May 14, 2024 | −$472.50 | −$455.00 | 3.70% | — | — |
| Q4 2023 | Mar 28, 2024 | −$630.00 | −$297.50 | 52.78% | — | — |
| Q3 2023 | Nov 14, 2023 | −$752.50 | −$700.00 | 6.98% | — | — |
| Q2 2023 | Aug 14, 2023 | −$962.50 | −$752.50 | 21.82% | — | — |
| Q1 2023 | May 15, 2023 | −$1,828.75 | −$1,627.50 | 11.00% | — | — |
| Q4 2022 | Mar 14, 2023 | −$1,575.00 | −$1,820.00 | -15.56% | $700,000.00 | — |
| Q3 2022 | Nov 14, 2022 | −$1,925.00 | −$1,750.00 | 9.09% | — | — |
| Q2 2022 | Aug 15, 2022 | −$1,925.00 | −$2,100.00 | -9.09% | — | — |
| Q1 2022 | May 12, 2022 | −$2,625.00 | −$2,450.00 | 6.67% | — | — |
| Q4 2021 | Mar 30, 2022 | −$2,800.00 | −$2,450.00 | 12.50% | $225,000.00 | — |
| Q3 2021 | Nov 15, 2021 | −$2,800.00 | −$2,100.00 | 25.00% | — | — |
| Q2 2021 | Aug 12, 2021 | −$2,450.00 | −$2,800.00 | -14.29% | — | — |
| Q1 2021 | May 17, 2021 | −$2,625.00 | −$2,100.00 | 20.00% | — | — |
| Q4 2020 | Mar 25, 2021 | −$5,075.00 | −$3,500.00 | 31.03% | — | — |

## Frequently Asked Questions

### When did Endra Life Sciences (NDRA) last report earnings?

Endra Life Sciences last reported on Nov 14, 2025, covering fiscal Q3 2025.

### Did NDRA beat earnings estimates?

No. Endra Life Sciences reported EPS of −$2.10 for Q3 2025 against a −$1.95 estimate — a 7.69% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).